|
|
||||||||
From the The Animal Cancer Center (Thamm), College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523; and the Department of Medical Sciences (Vail), School of Veterinary Medicine, University of Wisconsin Madison, Madison, Wisconsin 53704.
Most cytotoxic chemotherapy protocols used in small animals are designed to have a low risk of adverse effects; however, adverse events can occasionally occur. Timely and appropriate management of adverse events greatly increases client satisfaction and the likelihood of a successful treatment outcome. This article presents guidelines for the management of chemotherapy-associated hematological and gastrointestinal disturbances, extravasation injury, and anaphylaxis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |